Rare diseases
Investigational molecules
Locations
Aeschengraben 27, 4051
BeOne Medicines AG focuses extensively on chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Waldenström’s macroglobulinemia, and broader B-cell malignancies. Its research portfolio also includes mature B-cell malignancies and relapsed or refractory disease across these hematologic cancers.
The company’s clinical work in this area spans both previously untreated and relapsed or refractory settings, with a strong emphasis on lymphoid malignancies.
BeOne Medicines AG runs clinical trials in conditions such as Chronic lymphocytic leukaemia, B-cell small lymphocytic lymphoma, Mantle cell lymphoma refractory, Mantle cell lymphoma recurrent, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustriaAustria
Germany
Czechia
FranceAustriaFranceFranceFrance
ItalyAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
